TY - JOUR T1 - Lower levels of 25-hydroxyvitamin D<sub>3</sub> are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes JF - BMJ Open Diabetes Research &amp; Care JO - BMJ Open Diab Res Care DO - 10.1136/bmjdrc-2014-000058 VL - 3 IS - 1 SP - e000058 AU - Giacomo Zoppini AU - Anna Galletti AU - Giovanni Targher AU - Corinna Brangani AU - Isabella Pichiri AU - Maddalena Trombetta AU - Carlo Negri AU - Francesca De Santi AU - Vincenzo Stoico AU - Vittorio Cacciatori AU - Enzo Bonora Y1 - 2015/04/01 UR - http://drc.bmj.com/content/3/1/e000058.abstract N2 - Objective Low levels of serum 25-hydroxyvitamin D [25(OH)D] are commonly found in type 2 diabetes. We examined whether there is an association between circulating 25(OH)D concentrations and the presence of microvascular complications in people with type 2 diabetes.Research design and methods We studied 715 outpatients with type 2 diabetes who regularly attended our clinic. Participants were evaluated for the presence of microvascular complications (namely retinopathy and/or nephropathy) by clinical evaluation, fundus examination, urine examination and biochemical tests. Serum 25(OH)D levels were also measured for each participant.Results Hypovitaminosis D (ie, a serum 25(OH)D level &lt;30 ng/mL) was found in 75.4%, while deficiency (ie, a 25(OH)D level &lt;20 ng/mL) was found in 36.6% of these patients. Serum 25(OH)D levels decreased significantly in relation to the severity of either retinopathy or nephropathy or both. In multivariate logistic regression analysis, lower 25(OH)D levels were independently associated with the presence of microvascular complications (considered as a composite end point; OR 0.758; 95% CI 0.607 to 0.947, p=0.015). Notably, this association remained significant even after excluding those with an estimated glomerular filtration rate &lt;60 mL/min/1.73 m2.Conclusions We found an inverse and independent relationship between circulating 25(OH)D levels and the prevalence of microvascular complications in patients with type 2 diabetes. However, vitamin D may be simply a marker and causality cannot be implied from our cross-sectional study. Whether vitamin D supplementation in patients with type 2 diabetes may have beneficial effects on the risk of microvascular complications remains to be investigated. ER -